SABCS 2025 showcased several new strides in breast cancer research, which continues to be one of the most diagnosed malignancies globally, owing to the breadth of its subtypes: HR+, HER2+ and TNBC, all of which respond differently. In recent years, there have been several leaps in treatment options that have improved both outcomes and overall…